Cardiology Research Group

Medicine & Life Sciences

1. Acute Disease 11%
2. Adrenal Cortex Hormones 22%
3. Alleles 27%
4. Ambulatory Surgical Procedures 7%
5. Area Under Curve 8%
6. Asthma 29%
7. Autoimmune Hepatitis 47%
8. Bacteremia 38%
9. Biomarkers 26%
10. Blood Platelets 58%
11. BRCA1 Gene 30%
12. BRCA2 Gene 18%
13. Breast Neoplasms 48%
14. C-Reactive Protein 6%
15. Cardiac Tamponade 47%
16. Cell Line 11%
17. Centers for Disease Control and Prevention (U.S.) 38%
18. Clopidogrel 87%
19. Colombia 82%
20. Computer Simulation 8%
21. Congenital Heart Defects 7%
22. Coronary Artery Bypass 7%
23. Coronary Disease 9%
24. Costs and Cost Analysis 39%
25. Cross-Sectional Studies 24%
26. Databases 6%
27. Delayed Diagnosis 6%
28. Economics 29%
29. Epitopes 32%
30. Equipment and Supplies 15%
31. Erythrocyte Transfusion 9%
32. Ferritins 15%
33. Fibrinogen 7%
34. Forced Expiratory Volume 16%
35. Genes 30%
36. Heart Diseases 30%
37. Helium 6%
38. High-Throughput Nucleotide Sequencing 84%
39. History 7%
40. HLA-DRB1 Chains 50%
41. Hormones 6%
42. Hospitalization 27%
43. Infections 6%
44. Insulin 25%
45. Ipratropium 6%
46. Leukotriene Antagonists 6%
47. Live Birth 6%
48. Luciferases 8%
49. Lung 20%
50. Magnesium Sulfate 6%
51. Meningitis 18%
52. Meta-Analysis 28%
53. Metered Dose Inhalers 6%
54. Metformin 8%
55. MicroRNAs 31%
56. Mortality 7%
57. Multicenter Studies 32%
58. Mutation 7%
59. Neonatal Screening 7%
60. Neoplasms 12%
61. Newborn Infant 14%
62. Nucleic Acids 12%
63. Organism Cloning 8%
64. Outpatients 11%
65. Oximetry 45%
66. Oxygen 17%
67. Pandemics 13%
68. Peer Review 46%
69. Penetrance 10%
70. Pericardial Effusion 8%
71. Pharmaceutical Preparations 6%
72. Pharmacogenetics 12%
73. Pharmacogenomic Testing 100%
74. Pharmacology 25%
75. Physical Examination 26%
76. Pneumococcal Infections 18%
77. Pneumococcal Meningitis 54%
78. Pneumonia 27%
79. Polymerase Chain Reaction 22%
80. Population 52%
81. Regression Analysis 7%
82. Reporter Genes 9%
83. SARS Virus 55%
84. Secretagogues 18%
85. Sensitivity and Specificity 14%
86. Single Nucleotide Polymorphism 27%
87. Stomach Neoplasms 32%
88. Systematic Reviews 38%
89. Tertiary Care Centers 6%
90. Therapeutics 21%
91. Thoracic Surgery 34%
92. Transcutaneous Blood Gas Monitoring 10%
93. Translational Medical Research 24%
94. Transplants 12%
95. Triple Negative Breast Neoplasms 11%
96. Tumor Necrosis Factor-alpha 10%
97. Type 2 Diabetes Mellitus 28%
98. Viruses 8%
99. Vital Capacity 16%
100. Whole Exome Sequencing 11%